Brainlab Acquires VisionTree to Drive Patient-Reported Outcomes

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

Brainlab is a digital medical technology company. Today (January 22, 2020) the company announced the recent acquisition of VisionTree Software, Inc., a San Diego based company that develops cloud-based, patient-centric data collection and health management solutions.

The acquisition to Acquires VisionTree re-emphasizes the Brainlab commitment to quantifying medical procedure outcomes by taking a closer look at patients’ quality of life and condition after treatment. Brainlab investment into integrating objective measures into critical interventions follows the trend acknowledged by payers and providers from a fee-for-service towards a fee-for-value healthcare system.

Brainlab software today is digitally entrenched in a growing number of critical treatment workflows, generating a unique array of structured, validated, digital data. This workflow data is correlated with detailed anatomical data, stemming from the unique anatomical mapping capabilities of Brainlab. The results are powerful clinical registries with a wealth of otherwise hardly accessible data.

This effort is now enhanced by VisionTree in three ways:

  1. The company’s extensive experience in providing tools and standardized forms for collecting granular and well-structured outcomes data directly from consenting patients: More than 600 global healthcare providers and 2.5 million patients already rely on the VisionTree ePRO technology
  2. The VisionTree Optimal Care (VTOC) platform has proven integration capabilities with leading electronic health record (EHR), research and registry platforms
  3. VisionTree technology will allow the capture of semantically structured data otherwise only available in text format by using point-of-care electronic forms i.e. patient demographics during patient admission entered on a tablet PC

The established ePRO solution will complement the Brainlab cloud-based infrastructure and registry solution aiming to deliver patient engagement and even more comprehensive quality reporting. This will not only increase the quality and depth of data, but also further automate the data collection process while widening the company’s reach. Brainlab is committed to establishing a digital benchmark for medical data registries including medical image data to create a new standard for quality of care, quality control and research.

“I believe that patient data must ultimately be controlled by the patient. The acquisition of VisionTree adds a tool to our portfolio that will give the patient more control over the data that is generated by our systems for the benefit of better treatment,” said Stefan Vilsmeier, Brainlab President and Chief Executive Officer.

Brainlab will continue to invest in the VTOC platform aiming to facilitate data collection across all available sources including smart devices and wearables. At the same time, Brainlab will further enhance the VisionTree patient portal and enable patients to control the handling and processing of their data. By combining VTOC with its unique software ecosystem, Brainlab plans to offer streamlined and paperless workflows that combine patient-reported outcomes with anatomical information, treatment plans and surgical events to its more than 5,000 customers worldwide. Such unique aggregation of information along the digital data journey will open up new horizons for registries, clinical trials and all clinicians that believe in the potential of big data to improve treatments.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.